Pharmacokinetics of heparin after a single intravenous or subcutaneous injection. 1977

G Mombelli, and J Schaedelin, and E A Beck

In 2 groups of 4 probands the pharmacokinetics of heparin were investigated by a physiologic method (factor Xa inhibition) and an isotope method (35S-heparin) following a single intravenous injection of 5000 IU heparin and a single subcutaneous injection of 10000 IU heparin respectively. Following intravenous administration the anticoagulant effect and radioactivity fall exponentially. The half-life is about 50 min and the distribution volume 3000 ml (factor Xa inhibition) and 3800 ml (radioactivity). With subcutaneous injection peak concentrations above 0.2 IR heparin/ml were measured by both methods 2-4 h after administration; 9 h after administration, no further factor Xa inhibition was detectable in 2 probands. In the light of these and previously published results, some practical aspects of the conduct of therapy and prophylaxis of thromboembolism with heparin are discussed.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000990 Antithrombin III A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily. Heparin Cofactor I,Antithrombin III-Alpha,Atenativ,Heparin Co-Factor I,Kybernin,Serpin C1,Thrombate III,Antithrombin III Alpha,Antithrombin IIIAlpha,Cofactor I, Heparin,Heparin Co Factor I
D013460 Sulfur Isotopes Stable sulfur atoms that have the same atomic number as the element sulfur, but differ in atomic weight. S-33, 34, and 36 are stable sulfur isotopes. Isotopes, Sulfur

Related Publications

G Mombelli, and J Schaedelin, and E A Beck
March 2024, Journal of veterinary pharmacology and therapeutics,
G Mombelli, and J Schaedelin, and E A Beck
November 2019, Journal of veterinary pharmacology and therapeutics,
G Mombelli, and J Schaedelin, and E A Beck
March 1991, Journal of veterinary pharmacology and therapeutics,
G Mombelli, and J Schaedelin, and E A Beck
July 2020, Journal of veterinary pharmacology and therapeutics,
G Mombelli, and J Schaedelin, and E A Beck
October 2013, Journal of veterinary pharmacology and therapeutics,
G Mombelli, and J Schaedelin, and E A Beck
February 1988, Antimicrobial agents and chemotherapy,
G Mombelli, and J Schaedelin, and E A Beck
August 2017, Drug metabolism and pharmacokinetics,
G Mombelli, and J Schaedelin, and E A Beck
November 2022, The journal of allergy and clinical immunology. In practice,
G Mombelli, and J Schaedelin, and E A Beck
October 2000, Journal of veterinary pharmacology and therapeutics,
Copied contents to your clipboard!